1. iScience. 2023 Jun 28;26(7):107230. doi: 10.1016/j.isci.2023.107230.
eCollection  2023 Jul 21.

Alcohol-sourced acetate impairs T cell function by promoting cortactin 
acetylation.

Azizov V(1)(2), Hübner M(1)(2), Frech M(1)(2), Hofmann J(3), Kubankova M(4), 
Lapuente D(5), Tenbusch M(5), Guck J(4), Schett G(1)(2), Zaiss MM(1)(2).

Author information:
(1)Department of Internal Medicine 3, Rheumatology and Immunology, 
Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum 
Erlangen, Erlangen, Germany.
(2)Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-University 
Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
(3)Division of Biochemistry, Department of Biology, 
Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
(4)Max Planck Institute for the Science of Light & Max Planck Zentrum für Physik 
und Medizin, Erlangen, Germany.
(5)Institute of Clinical and Molecular Virology, Friedrich-Alexander-University 
Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Alcohol is among the most widely consumed dietary substances. Excessive alcohol 
consumption damages the liver, heart, and brain. Alcohol also has strong 
immunoregulatory properties. Here, we report how alcohol impairs T cell function 
via acetylation of cortactin, a protein that binds filamentous actin and 
facilitates branching. Upon alcohol consumption, acetate, the metabolite of 
alcohol, accumulates in lymphoid organs. T cells exposed to acetate, exhibit 
increased acetylation of cortactin. Acetylation of cortactin inhibits 
filamentous actin binding and hence reduces T cell migration, immune synapse 
formation and activation. While mutated, acetylation-resistant cortactin rescues 
the acetate-induced inhibition of T cell migration, primary mouse cortactin 
knockout T cells exhibited impaired migration. Acetate-induced cytoskeletal 
changes effectively inhibited activation, proliferation, and immune synapse 
formation in T cells in vitro and in vivo in an influenza infection model in 
mice. Together these findings reveal cortactin as a possible target for 
mitigation of T cell driven autoimmune diseases.

© 2023 The Author(s).

DOI: 10.1016/j.isci.2023.107230
PMCID: PMC10362326
PMID: 37485352

Conflict of interest statement: The authors declare no competing interests.